[Neurotoxicity of vidarabine in chronic active hepatitis]. 1985

G Chauplannaz, and C Trepo, and B Bady, and A M Brunon

UI MeSH Term Description Entries
D010523 Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. Peripheral Nerve Diseases,Peripheral Neuropathies,PNS (Peripheral Nervous System) Diseases,PNS Diseases,Peripheral Nervous System Disease,Peripheral Nervous System Disorders,Nerve Disease, Peripheral,Nerve Diseases, Peripheral,Neuropathy, Peripheral,PNS Disease,Peripheral Nerve Disease,Peripheral Neuropathy
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014740 Vidarabine A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus. Adenine Arabinoside,Ara-A,Arabinofuranosyladenine,Arabinosyladenine,9-beta-Arabinofuranosyladenine,9-beta-D-Arabinofuranosyladenine,Ara A,Vira-A,alpha-Ara A,alpha-D-Arabinofuranosyladenine,beta-Ara A,9 beta Arabinofuranosyladenine,9 beta D Arabinofuranosyladenine,Arabinoside, Adenine,Vira A,ViraA,alpha Ara A,alpha D Arabinofuranosyladenine,beta Ara A

Related Publications

G Chauplannaz, and C Trepo, and B Bady, and A M Brunon
January 1986, Journal of hepatology,
G Chauplannaz, and C Trepo, and B Bady, and A M Brunon
June 1992, La Revue du praticien,
G Chauplannaz, and C Trepo, and B Bady, and A M Brunon
January 1993, Gastroenterologie clinique et biologique,
G Chauplannaz, and C Trepo, and B Bady, and A M Brunon
January 1987, Gastroenterologie clinique et biologique,
G Chauplannaz, and C Trepo, and B Bady, and A M Brunon
April 1978, JAMA,
G Chauplannaz, and C Trepo, and B Bady, and A M Brunon
April 1988, Deutsche medizinische Wochenschrift (1946),
G Chauplannaz, and C Trepo, and B Bady, and A M Brunon
October 1986, Gastroenterologie clinique et biologique,
G Chauplannaz, and C Trepo, and B Bady, and A M Brunon
January 2001, Journal of pediatric hematology/oncology,
G Chauplannaz, and C Trepo, and B Bady, and A M Brunon
April 1982, JAMA,
Copied contents to your clipboard!